Evidence map›Paper›PMID 31969206›Full record

ArticleInfection control and hospital epidemiology2020

Assessment of antibiotic-resistant organism transmission among rooms of hospitalized patients, healthcare personnel, and the hospital environment utilizing surrogate markers and selective bacterial cultures.

Jennie H Kwon, Kimberly Reske, Caroline A O'Neil, Candice Cass, Sondra Seiler, Meghan A Wallace, Tiffany Hink, Stephen Y Liang, Victoria J Fraser, Carey-Ann D Burnham and 2 more

Abstract readComparative Study
In one paragraph

Article in Infection control and hospital epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jennie H KwonDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.ORCID https://orcid.org/0000-0002-7824-6276
Kimberly ReskeDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.ORCID https://orcid.org/0000-0003-4752-8796
Caroline A O'NeilDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Candice CassDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Sondra SeilerDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Meghan A WallaceDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, Missouri.
Tiffany HinkDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Stephen Y LiangDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
Victoria J FraserDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.ORCID https://orcid.org/0000-0001-6251-0733
Carey-Ann D BurnhamDepartment of Pathology & Immunology, Washington University School of Medicine, St Louis, Missouri.ORCID https://orcid.org/0000-0002-1137-840X
Erik R DubberkeDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.ORCID https://orcid.org/0000-0003-3779-2796
CDC Prevention Epicenters Program

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
Longitudinal Analysis of the Fecal Microbiome and Resistome of Patients with Multidrug-Resistant Urinary Tract Infections and Predictors of RecurrenceK23AI137321 · NIAID · WASHINGTON UNIVERSITY · PI KWON, JENNIE H · 2019 to 2022
$675k
NCATS NIH HHS KL2 TR000450NCATS NIH HHS KL2 TR002346NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCEZID CDC HHS U54 CK000162NCEZID CDC HHS U54 CK000609NIAID NIH HHS K23 AI137321
6 · The paper itself

Abstract

objectiveTo assess potential transmission of antibiotic-resistant organisms (AROs) using surrogate markers and bacterial cultures.

designPilot study.

settingA 1,260-bed tertiary-care academic medical center.

participantsThe study included 25 patients (17 of whom were on contact precautions for AROs) and 77 healthcare personnel (HCP).

methodsFluorescent powder (FP) and MS2 bacteriophage were applied in patient rooms. HCP visits to each room were observed for 2-4 hours; hand hygiene (HH) compliance was recorded. Surfaces inside and outside the room and HCP skin and clothing were assessed for fluorescence, and swabs were collected for MS2 detection by polymerase chain reaction (PCR) and selective bacterial cultures.

resultsTransfer of FP was observed for 20 rooms (80%) and 26 HCP (34%). Transfer of MS2 was detected for 10 rooms (40%) and 15 HCP (19%). Bacterial cultures were positive for 1 room and 8 HCP (10%). Interactions with patients on contact precautions resulted in fewer FP detections than interactions with patients not on precautions (P < .001); MS2 detections did not differ by patient isolation status. Fluorescent powder detections did not differ by HCP type, but MS2 was recovered more frequently from physicians than from nurses (P = .03). Overall, HH compliance was better among HCP caring for patients on contact precautions than among HCP caring for patients not on precautions (P = .003), among nurses than among other nonphysician HCP at room entry (P = .002), and among nurses than among physicians at room exit (P = .03). Moreover, HCP who performed HH prior to assessment had fewer fluorescence detections (P = .008).

conclusionsContact precautions were associated with greater HCP HH compliance and reduced detection of FP and MS2.

Indexed as

Equipment ContaminationAcademic Medical CentersBacteriophagesCross InfectionDrug Resistance, Multiple, BacterialGuideline AdherenceHand HygieneHealth PersonnelHospitalizationHospitalsHumansPatientsPilot Projects

Identifiers

PMID31969206
PMCPMC7592156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.